Using CD47's protection to deliver anti-cancer drugs directly to tumor cells

October 9, 2012 by Marcia Goodrich
Ching-An Peng with students in his lab. Peng is studying new ways to get chemotherapy drugs to the site of a tumor.

(Medical Xpress)—For most of their natural lives, red blood cells hide safely under the radar of the body's immune system, thanks to a cloak of "don't eat me" protein called CD47. Ching-An Peng of Michigan Technological University wants to co-opt that clever trick to fight cancer.

Voracious called macrophages normally protect organisms by engulfing cell debris and pathogens. However, if they encounter something covered with CD47, such as a red blood cell, they tend to leave it alone. "I thought, 'Why not use CD47 to help deliver drugs?" said Peng. "We could camouflage them and avoid the immune response."

Nanoparticles hold great promise for delivering anti- directly to the site of a tumor. Getting them there, however, has been problematic, since macrophages stand at the ready to scoop the particles out of the blood stream before they can get to the the tumor and drop their cargo. Peng theorizes that if drug-bearing nanoparticles were coated with CD47, they could make it to the tumor unmolested.

CD47 also brings another weapon to the war against cancer. It binds to a special kind of protein found on tumors called an integrin. This integrin is involved with the network of that form around the tumor, blood vessels that provide the cancer with nutrients to fuel its out-of-control growth.

Thus, properly designed CD47-coated nanoparticles might deliver a one-two punch to cancer by 1) delivering and 2) choking off its food supply.

Research by Peng and his colleagues is in its early stages. They are using E. coli bacteria to mass produce CD47 in the lab using recombinant DNA technology. The next step will be to attach it to nanoparticles and expose them to macrophages, to see if the macrophages eat them up or—hopefully—ignore them.

Explore further: Research: Single antibody shrinks variety of human tumors transplanted into mice

Related Stories

Recommended for you

Research holds promise for personalized lung cancer treatments

January 12, 2017

New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah uncovered distinct types of tumors within small cell lung cancer that look and act differently from one another. Scientists also identified ...

Tumor-seeking salmonella treats brain tumors

January 11, 2017

Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer—a strain of salmonella that usually causes food poisoning.

New genes identified that regulate the spread of cancers

January 11, 2017

Research led by the Wellcome Trust Sanger Institute has discovered a new biological target for drugs to reduce the spread of tumours in cancer patients. Published in Nature today, the study with genetically modified mice ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.